Search Results - "Herbst, Cameron"

Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease–associated Colorectal Dysplasia and Adenocarcinoma by Ma, Changqing, Henn, Patrick, Miller, Caitlyn, Herbst, Cameron, Hartman, Douglas J, Pai, Reetesh K

“…SATB2 is a sensitive immunohistochemistry marker of colorectal carcinoma and non-neoplastic colorectal epithelium that is complementary to CDX2. However, its…”
Get full text

SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer by Ma, Changqing, Olevian, Dane, Miller, Caitlyn, Herbst, Cameron, Jayachandran, Priya, Kozak, Margaret M., Chang, Daniel T., Pai, Reetesh K.

“…DNA mismatch repair protein deficient colon cancer frequently displays reduced CDX2 expression, and recent literature has suggested that negative CDX2…”
Get full text

Comparison of PD‐L1 immunohistochemistry assays and response to PD‐1/L1 inhibitors in advanced non‐small‐cell lung cancer in clinical practice by Villaruz, Liza C, Ancevski Hunter, Katerina, Kurland, Brenda F, Abberbock, Shira, Herbst, Cameron, Dacic, Sanja

“…Aims Several studies have demonstrated analytical comparability between different PD‐L1 assays, but their clinical validity in non‐small‐cell lung cancer in…”
Get full text

Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation by Hartman, Douglas J, Binion, David G, Regueiro, Miguel D, Miller, Caitlyn, Herbst, Cameron, Pai, Reetesh K

“…Abstract Background Chronic idiopathic inflammatory bowel disease (IBD) is a significant risk factor for the development of intestinal adenocarcinoma. The…”
Get full text